Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Ceftiofur hydrochloride
Vetoquinol Ireland Limited
QJ01DD90
Ceftiofur hydrochloride
50 milligram(s)/millilitre
Suspension for injection
POM: Prescription Only Medicine as defined in relevant national legislation
ceftiofur
Authorised
2017-12-08
Health Products Regulatory Authority 27 September 2019 CRN009282 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ceftiocyl Fluid 50 mg/ml, suspension for injection for pigs and cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: ACTIVE SUBSTANCE(S): Ceftiofur (as hydrochloride) 50.0 mg EXCIPIENT(S): For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Suspension for injection. Slightly yellow to slightly pink, milky suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Infections associated with bacteria sensitive to ceftiofur: In pigs: For the treatment of bacterial respiratory disease associated with Pasteurella multocida, Actinobacillus pleuropneumoniae and Streptococcus suis. In cattle: For the treatment of bacterial respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. For the treatment of acute interdigital necrobacillosis, (panaritium, foot rot), associated with Fusobacterium necrophorum and Bacteroides melaninogenicus. For treatment of the bacterial component of acute post-partum (puerperal) metritis within 10 days after calving associated with Escherichia coli, Trueperella pyogenes (former Arcanobacterium pyogenes) and Fusobacterium necrophorum, sensitive to ceftiofur, where treatment with another antimicrobial has failed. 4.3 CONTRAINDICATIONS Do not inject intravenously. Do not use in poultry (including eggs) due to the risk of spread of antimicrobial resistance to humans. Do not use in cases of hypersensitivity to ceftiofur, to any other β-lactam antibiotics, or to any of the excipients. Do not use in cases of known resistance to ceftiofur or other β-lactam antibiotics. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known. Health Products Regulatory Authority 27 September 2019 CRN009282 Page 2 of 6 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals In case of the occurrence of allergi Read the complete document